Financhill
Back

ProQR Therapeutics NV Stock Predictions

ProQR Therapeutics NV Stock Forecast

  • Is ProQR Therapeutics NV Stock Undervalued?
    The current ProQR Therapeutics NV [PRQR] share price is $2.66. The Score for PRQR is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • PRQR is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will ProQR Therapeutics NV Stock Go Up Next Year?

Data Unavailable

ProQR Therapeutics NV Stock Rating

Data Unavailable

ProQR Therapeutics NV Stock Price History

Is PRQR stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRQR is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Netherlands
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
proqr.com

52-Week Data

52-Week High:
4.62
52-Week Low:
1.61

Prediction Charts

Market Cap:
281.2M
Price in USD:
2.66
Volume:
547.3K
Beta:
0.26

Technical Analysis

SMA50:
3.39
SMA100:
2.65
SMA200:
2.31
52-Wk Change:
35.46%

Stock Predictions

  • Is ProQR Therapeutics NV stock public?
    Yes, ProQR Therapeutics NV is a publicly traded company.
  • What is the ProQR Therapeutics NV stock quote today?
    The ProQR Therapeutics NV stock price is 2.66 USD today.
  • How to buy ProQR Therapeutics NV stock online?
    You can buy ProQR Therapeutics NV shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 3.55 3.67 3.70 3.46
Dec-4 3.63 3.47 3.63 3.45
Dec-5 3.50 3.54 3.67 3.45
Dec-6 3.54 3.56 3.63 3.52
Dec-9 3.61 3.45 3.71 3.41
Dec-10 3.44 3.31 3.52 3.26
Dec-11 3.45 3.38 3.45 3.30
Dec-12 3.40 3.29 3.46 3.23
Dec-13 3.27 2.83 3.27 2.82
Dec-16 2.73 2.47 2.81 2.27
Dec-17 2.46 2.94 2.95 2.40
Dec-18 2.89 2.56 2.95 2.52
Dec-19 2.70 2.59 2.70 2.48
Dec-20 2.59 2.66 2.71 2.48

ProQR Therapeutics NV Earnings

Data Unavailable

ProQR Therapeutics NV Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.07 per share.

* ProQR Therapeutics NV stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.